TXNDC16 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.354200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.751000E-01
Normal-vs-Stage2
2.331600E-01
Normal-vs-Stage3
2.770200E-02
Normal-vs-Stage4
8.943600E-01
Stage1-vs-Stage2
4.855000E-01
Stage1-vs-Stage3
1.252600E-01
Stage1-vs-Stage4
6.075800E-01
Stage2-vs-Stage3
1.865580E-01
Stage2-vs-Stage4
2.233600E-01
Stage3-vs-Stage4
2.328100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.172600E-01
Normal-vs-AfricanAmerican
6.982000E-01
Normal-vs-Asian
2.835800E-01
Caucasian-vs-AfricanAmerican
4.416600E-01
Caucasian-vs-Asian
7.244400E-01
AfricanAmerican-vs-Asian
4.074600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.294000E-01
Normal-vs-Female
4.599600E-01
Male-vs-Female
5.146600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.958000E-01
Normal-vs-Age(41-60Yrs)
5.223400E-01
Normal-vs-Age(61-80Yrs)
3.072800E-01
Normal-vs-Age(81-100Yrs)
4.586000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.196200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.498000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.482000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.077600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.300200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.826970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.657800E-02
Normal-vs-Daily Drinker
7.165500E-02
Normal-vs-Weekly Drinker
1.048560E-01
Normal-vs-Occasional Drinker
6.822600E-01
Normal-vs-Social Drinker
8.052600E-01
Non Drinker-vs-Daily Drinker
4.553600E-01
Non Drinker-vs-Weekly Drinker
6.960200E-01
Non Drinker-vs-Occasional Drinker
3.608600E-01
Non Drinker-vs-Social Drinker
2.904800E-01
Daily Drinker-vs-Weekly Drinker
8.101200E-01
Daily Drinker-vs-Occasional Drinker
2.055800E-01
Daily Drinker-vs-Social Drinker
1.754570E-01
Weekly Drinker-vs-Occasional Drinker
2.858800E-01
Weekly Drinker-vs-Social Drinker
2.335800E-01
Occasional Drinker-vs-Social Drinker
8.153600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.772800E-01
Normal-vs-Grade 2
4.333900E-02
Normal-vs-Grade 3
3.787700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.338400E-01
Grade 1-vs-Grade 3
4.161200E-01
Grade 1-vs-Grade 4
1.772800E-01
Grade 2-vs-Grade 3
9.106400E-01
Grade 2-vs-Grade 4
4.333900E-02
Grade 3-vs-Grade 4
3.787700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.227700E-02
Normal-vs-NonDiabetic
3.524200E-01
Diabetic-vs-NonDiabetic
2.024200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.779700E-02
Normal-vs-NoPancreatitis
3.427600E-01
Pancreatitis-vs-NoPancreatitis
1.652800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.393800E-01
Normal-vs-N1
1.964230E-01
N0-vs-N1
2.306200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.747400E-01
Normal-vs-TP53-NonMutant
8.287800E-01
TP53-Mutant-vs-TP53-NonMutant
2.856400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
